Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception, trial modernization, and patient-first evidence.Continue reading
Monthly Archives: September 2025
XLR8 PBC Introduces Fall 2025 Cohort
XLR8 PBC has cemented its role as a unique and highly impactful program within the health tech ecosystem. A strategic launchpad for companies poised for significant growth and market penetration, the program has been designed to support founders/CEOs with access to top industry leaders, mentorship, and strategic resources.
New Arizona’s Bioscience Roadmap: How the state becomes a nationally recognized bioscience hub
The Flinn Foundation releases a new Arizona’s Bioscience Roadmap to guide industry discovery, innovation, and economic growth for the next five years. The new plan builds on Arizona’s talent base, world-class research, and entrepreneurial spirit to improve the economy as well as Arizonans’ health and quality of life. Developed by SRI International of Menlo Park, Calif., the Roadmap launches at stakeholder events statewide and online the week of Sept. 8, 2025.Continue reading
C-Path’s Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology
Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million in 2025 to projects in the U.S., Europe and AustraliaContinue reading
Flinn Foundation Translational Seed Grants Program – Apply by Oct. 31 2025
It’s that time of the year again. The Flinn Foundation is seeking applicants for the 11th cohort of its Translational Seed Grants Program! The RFP opened Sept. 3, 2025 and closes on Friday, Oct. 31.Continue reading